CVC  Cencora Ventures

https://www.cencora.com/





     Office Locations:

1 West First Avenue
Conshohocken, PA 19428

 
Stages:

  • Expansion
  • Growth


 
Industries:

  • Life Sciences & Healthcare

  •  
    Description:

    Cencora combines core pharmaceutical distribution with innovative business solutions to help our partners across the healthcare spectrum get medications to the patients who need them.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     
    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Elizabeth Campbell Executive Vice President and Chief Legal Officer
    Francois Mandeville Executive Vice President and Chief Strategy and M&A Officer
    James F. Cleary Executive Vice President and Chief Financial Officer
    Juan Guerra EVP and President, International Business Group
    Pawan Verma Executive Vice President and Chief Data and Information Officer

     
    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      01/13/2026


      RISA Labs


      CA


      $11,100,000


      Series A


      03/05/2025


      Lumata


      OK


      $23,000,000


      Series B


     
    Portfolio companies include:


      Atropos Health
        web link


      Lumata
        web link


      RISA Labs
        web link


      Sempre Health
        web link


     
    Recent News: